Benjamin O. Looker's most recent trade in Esperion Therapeutics Inc. was a trade of 1,304 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on July 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Esperion Therapeutics Inc. | Benjamin O. Looker | General Counsel | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 17 Jul 2025 | 1,304 | 399,937 (1%) | 0% | 1.1 | 1,470 | Common Stock |
| Esperion Therapeutics Inc. | Benjamin O. Looker | General Counsel | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 17 Jun 2025 | 6,422 | 401,241 (1%) | 0% | 1.2 | 7,398 | Common Stock |
| Esperion Therapeutics Inc. | Benjamin O. Looker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 224,000 | 407,663 (1%) | 0% | 0 | Common Stock | |
| Esperion Therapeutics Inc. | Benjamin O. Looker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 201,000 | 201,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc. | Benjamin O. Looker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc. | Benjamin O. Looker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 100,000 | 183,663 (0%) | 0% | 0 | Common Stock | |
| Esperion Therapeutics Inc. | Benjamin O. Looker | General Counsel | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 19 Apr 2023 | 1,290 | 83,663 (0%) | 0% | 1.3 | 1,641 | Common Stock |
| Esperion Therapeutics Inc. | Benjamin O. Looker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 86,900 | 86,900 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc. | Benjamin O. Looker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 20,500 | 84,953 (0%) | 0% | 0 | Common Stock | |
| Esperion Therapeutics Inc. | Benjamin O. Looker | General Counsel | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 18 Jan 2023 | 6,347 | 64,453 (0%) | 0% | 7.0 | 44,404 | Common Stock |
| Esperion Therapeutics Inc. | Benjamin O. Looker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 52,000 | 52,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc. | Benjamin O. Looker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 100,450 | 100,450 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc. | Benjamin O. Looker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 70,800 | 70,800 (0%) | 0% | 0 | Common Stock |